IQVIA Life Sciences Innovation Forum 2022
The IQVIA Life Sciences Innovation Forum was born of a desire to drive innovation and further advance healthcare. The inaugural Forum in 2022 was a virtual, multi-stakeholder, non-commercial public event hosted by the IQVIA Institute on September 12-16. Each session included a presentation of new research data and analytics and offered provocative commentaries and lively and engaging discussions with leaders and experts from the life sciences industry and select stakeholders.
See details of each session below, including a list of speakers, links to view each session on-demand, set-up slides for each session, and links to applicable content and resources.
Day 1, September 12, 2022
Addressing Unmet Healthcare Needs: How do we prioritize unmet healthcare needs and accelerate innovation?
Day 2, September 13, 2022
Evolving the Biomedical Innovation System: How do we improve R&D productivity sufficiently to sustain innovation?
Day 3, September 14, 2022
Maximizing the Value of Medicines to Patients: How do we achieve higher value from available medicines?
Day 4, September 15, 2022
Advancing Health System Sustainability: How do we assess what is sustainable, affordable, and equitable?
Day 5, September 16, 2022
Re-Thinking the Life Sciences Business Model: How do we ensure the business model evolves successfully?
Day 1, September 12, 2022
Addressing Unmet Health Care Needs: This first day of the Life Sciences Innovation Forum covered assessing innovation needs, identifying new pathways, balancing disease and innovation priorities, access to innovation, and the promise of “curative” therapies.
Speakers:
Olawale (Wale) Ajose, MPH
Managing Partner, Market Access Africa
Thomas Cueni, MS
Director General, IFPMA
Bengt Jönsson, Ph.D.
Professor Emeritus of Health Economics, Stockholm School of Economics
Addressing Unmet Healthcare Needs: How do we prioritize unmet healthcare needs and accelerate innovation?
The IQVIA Life Sciences Forum was born of a desire to drive innovation and further advance healthcare. Each session will begin with a presentation of new research data and analytics and will continue with provocative commentaries and lively and engaging discussions with leaders and experts from the life sciences industry and select stakeholders.
IQVIA Life Sciences Innovation Forum
Addressing Unmet Healthcare Needs
Addressing Unmet Healthcare Needs: How do we prioritize unmet healthcare needs and accelerate innovation?
Solving unmet healthcare needs is at the top of the agenda for policymakers and international organizations, but there is no global consensus about what constitutes the most urgent priorities, and there are huge variations in access to innovations between countries at all income levels and across the globe.
Resource list
Scaling-Up Inclusive Healthcare Initiatives in Low- and Middle-Income Countries
Assessing the landscape of innovative approaches
Day 2, September 13, 2022
Evolving the Biomedical Innovation System: Day two of the Life Sciences Innovation Forum looked at the regulatory environment, clinical trial productivity, the role of real-world evidence and advanced analytics, sustainability of the innovation system, and collaborative models.
Speakers:
David Arons, JD
CEO, National Brain Tumor Society
Patrick Caubel, MD, Ph.D.
Chief Safety Officer, Pfizer
Ken Getz, MBA
Executive Director, Research Professor, Tufts Center for the Study of Drug Development
Patrick Maxwell, MD
Regius Professor of Physic, University of Cambridge
Nicole Connelly, Ph.D.
Research Director, IQVIA Institute for Human Data Science
Evolving the Biomedical Innovation System: How do we improve R&D productivity sufficiently to sustain innovation?
The IQVIA Life Sciences Forum was born of a desire to drive innovation and further advance healthcare. Each session will begin with a presentation of new research data and analytics and will continue with provocative commentaries and lively and engaging discussions with leaders and experts from the life sciences industry and select stakeholders.
IQVIA LIFE SCIENCES INNOVATION FORUM
Evolving the Biomedical Innovation System
Resource list
Lesson Learned from COVID-19 Vaccine Trials
A CRO perspective on accelerating clinical development
Emerging Biopharma’s Contribution to Innovation
Day 3, September 14, 2022
Maximizing the Value of Medicines to Patients: Day three of the Life Sciences Innovation Forum included discussions around how to achieve higher value from available medicines, including personalized medicines, the importance of technology, and home-based care.
Speakers:
Josh Benner, PharmD, ScD
CEO, RxAnte
Jisella Dolan, JD
Chief Global Advocacy Office,r Home Instead + Honor Technology
Rob Glik, MBA
VP & GM, Value & Access Strategy Consulting, IQVIA
Daryl Pritchard, Ph.D.
SVP, Science Policy, Personalized Medicine Coalition
Vibhu Tewary, MBA
Project Director, IQVIA Institute for Human Data Science
Maximizing the Value of Medicines to Patients: How do we achieve higher value from available medicines?
The IQVIA Life Sciences Forum was born of a desire to drive innovation and further advance healthcare. Each session will begin with a presentation of new research data and analytics and will continue with provocative commentaries and lively and engaging discussions with leaders and experts from the life sciences industry and select stakeholders.
IQVIA LIFE SCIENCES INNOVATION FORUM
Maximizing the Value of Medicines to Patients
Day 4, September 15, 2022
Advancing Health System Sustainability: Discussions on the fourth day of the Life Sciences Innovation Forum focused on defining sustainability, contributors to sustainability, overcoming disparities, the role of life sciences companies, and medicine spending.
Speakers:
Francesca Colombo, MSc
Head of Health Division, OECD
David Cutler, Ph.D.
Otto Eckstein Professor of Applied Economics, Harvard University
Michael Kleinrock, MA
Research Director, IQVIA Institute for Human Data Science
Advancing Health System Sustainability: How do we assess what is sustainable, affordable, and equitable?
The IQVIA Life Sciences Forum was born of a desire to drive innovation and further advance healthcare. Each session will begin with a presentation of new research data and analytics and will continue with provocative commentaries and lively and engaging discussions with leaders and experts from the life sciences industry and select stakeholders.
IQVIA LIFE SCIENCES INNOVATION FORUM
Advancing Health System Sustainability
Day 5, September 16, 2022
Re-thinking the Life Sciences Business Model: The fifth and final day of the Life Sciences Innovation Forum considered how we might re-think the life sciences business model, including speed and agility, disruptors, balancing risk and reward, radical patient engagement, and the future of life sciences companies.
Speakers:
Arvind Balasundaram, MBA
Executive Director, Commercial Insights & Analytics, Regeneron
AJ Ploszay, Ph.D., MSc
SVP & Chief Digital and Marketing Officer, IQVIA
Kent Rogers, MBA
Chief Customer Officer, EQRx
Mark Trusheim, MS
NEWDIGS, Tufts Medical Center
Michael Kleinrock, MA
Research Director, IQVIA Institute
Re-Thinking the Life Sciences Business Model: How do we ensure the business model evolves successfully?
The IQVIA Life Sciences Forum was born of a desire to drive innovation and further advance healthcare. Each session will begin with a presentation of new research data and analytics and will continue with provocative commentaries and lively and engaging discussions with leaders and experts from the life sciences industry and select stakeholders.
IQVIA LIFE SCIENCES INNOVATION FORUM
Re-thinking the Life Sciences Business Model
Resource list
The Use of Medicines in the U.S. 2022
Usage and spending trends and outlook to 2026